drugset / Trial / NCT05154955

A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat

NCT05154955

Phase 2 Completed 51 enrolled 10xBio, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this research study is to determine the safety and efficacy of 10XB-101 vs. vehicle (placebo) for adults with excessive submental fat (SMF).

Timeline

Start
2021-10-19
Primary completion
2024-03-19
Completion
2024-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Polidocanol Other / unclassified 2 % Subcutaneous
Subject Polidocanol Other / unclassified 3 % Subcutaneous
Subject Polidocanol Other / unclassified 4.5 % Subcutaneous

Indications

No indication recorded.